Equifax Stock Issuance Proceeds increased by 25.3% to $10.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $12.30M to $10.40M. Over 4 years (FY 2021 to FY 2025), Stock Issuance Proceeds shows relatively stable performance with a -0.2% CAGR.
Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.
Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...
Standard for large-cap companies with significant equity-based compensation programs.
proceeds_from_stock_issuance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.50M | $8.30M | $13.40M | $5.70M | $3.00M | $4.80M | $3.40M | $6.60M | $9.90M | $2.10M | $13.70M | $19.90M | $18.20M | $29.40M | $10.70M | $12.30M | $12.10M | $13.70M | $8.30M | $10.40M |
| QoQ Change | — | -55.1% | +61.4% | -57.5% | -47.4% | +60.0% | -29.2% | +94.1% | +50.0% | -78.8% | +552.4% | +45.3% | -8.5% | +61.5% | -63.6% | +15.0% | -1.6% | +13.2% | -39.4% | +25.3% |
| YoY Change | — | — | — | — | -83.8% | -42.2% | -74.6% | +15.8% | +230.0% | -56.3% | +302.9% | +201.5% | +83.8% | >999% | -21.9% | -38.2% | -33.5% | -53.4% | -22.4% | -15.4% |